Literature DB >> 25816993

18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?

A Tuba Kendi1, Amanda Corey2, Kelly R Magliocca3, Dana C Nickleach4, James Galt2, Jeffrey M Switchenko4, Mark W El-Deiry5, J Trad Wadsworth5, Patricia A Hudgins2, Nabil F Saba6, David M Schuster2.   

Abstract

PURPOSE: This study was designed to seek associations between positron emission tomography/computed tomography (PET/CT) parameters, contrast enhanced neck computed tomography (CECT) and pathological findings, and to determine the potential prognostic value of PET/CT and CECT parameters in oral cavity squamous cell carcinoma (OCSCC). MATERIALS AND
METHOD: 36 OCSCC patients underwent staging PET/CT and 30/36 of patients had CECT. PET/CT parameters were measured for the primary tumor and the hottest involved node, including maximum, mean, and peak standardized uptake values (SUV max, SUV mean, and SUV peak), metabolic tumor volume (MTV), total lesion glycolysis (TLG), standardized added metabolic activity (SAM), and normalized standardized added metabolic activity (N SAM). Qualitative assessment of PET/CT and CECT were also performed. Pathological outcomes included: perineural invasion, lymphovascular invasion, nodal extracapsular spread, grade, pathologic T and N stages. Multivariable logistic regression models were fit for each parameter and outcome adjusting for potentially confounding variables. Multivariable Cox proportional hazards models were used for progression free survival (PFS), locoregional recurrence free survival (LRFS), overall survival (OS) and distant metastasis free survival (DMFS).
RESULTS: In multivariable analysis, patients with high (≥ median) tumor SUV max (OR 6.3), SUV mean (OR 6.3), MTV (OR 19.0), TLG (OR 19.0), SAM (OR 11.7) and N SAM (OR 19.0) had high pathological T-stage (T3/T4) (p<0.05). Ring/heterogeneous pattern on CECT qualitative assessment was associated with worse DMFS and OS.
CONCLUSION: High PET/CT parameters were associated with pathologically advanced T stage (T3/T4). Qualitative assessment of CECT has prognostic value. PET/CT parameters did not predict clinical outcome.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography; Head and neck carcinoma; Positron emission tomography; Squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 25816993      PMCID: PMC4927192          DOI: 10.1016/j.ejrad.2015.02.030

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  18 in total

1.  Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.

Authors:  James D Murphy; Trang H La; Karen Chu; Andrew Quon; Nancy J Fischbein; Peter G Maxim; Edward E Graves; Billy W Loo; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

2.  TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival.

Authors:  Oluwafunmilola T Okuyemi; Jay F Piccirillo; Edward Spitznagel
Journal:  Head Neck       Date:  2014-01-13       Impact factor: 3.147

3.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

Review 4.  Head and neck cancer.

Authors:  Michael J Walden; Nafi Aygun
Journal:  Semin Roentgenol       Date:  2013-01       Impact factor: 0.800

5.  18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.

Authors:  Remy Lim; Anne Eaton; Nancy Y Lee; Jeremy Setton; Nisha Ohri; Shyam Rao; Richard Wong; Matthew Fury; Heiko Schöder
Journal:  J Nucl Med       Date:  2012-08-14       Impact factor: 10.057

6.  18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging.

Authors:  Elizabeth H Dibble; Ana C Lara Alvarez; Minh-Tam Truong; Gustavo Mercier; Earl F Cook; Rathan M Subramaniam
Journal:  J Nucl Med       Date:  2012-04-09       Impact factor: 10.057

7.  Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.

Authors:  Yasser G Abd El-Hafez; Hosna M Moustafa; Haytham F Khalil; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Oral Oncol       Date:  2012-10-01       Impact factor: 5.337

8.  FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.

Authors:  Vasavi Paidpally; Alin Chirindel; Stella Lam; Nishant Agrawal; Harry Quon; Rathan M Subramaniam
Journal:  Imaging Med       Date:  2012-12

9.  Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.

Authors:  Yoshiaki Zaizen; Koichi Azuma; Seiji Kurata; Eiji Sadashima; Satoshi Hattori; Tetsuro Sasada; Yohei Imamura; Hayato Kaida; Akihiko Kawahara; Takashi Kinoshita; Masatoshi Ishibashi; Tomoaki Hoshino
Journal:  Eur J Radiol       Date:  2012-08-09       Impact factor: 3.528

Review 10.  Pitfalls in the staging of cancer of oral cavity cancer.

Authors:  Ashley H Aiken
Journal:  Neuroimaging Clin N Am       Date:  2013-02       Impact factor: 2.264

View more
  3 in total

1.  Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne-Kathrin Höhn; Karsten Winter; Osama Sabri; Sandra Purz
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

2.  18F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging.

Authors:  G Paone; F Martucci; V Espeli; L Ceriani; G Treglia; T Ruberto; A Richetti; R Piantanida; L Giovanella
Journal:  Contrast Media Mol Imaging       Date:  2019-09-11       Impact factor: 3.161

3.  18F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting overall survival of oral cavity squamous cell carcinoma: Ongoing controversy.

Authors:  Stephen Scott; J Kenneth Byrd; Ramon Figueroa; Hadyn Williams; Jie Chen; Jaeeun Lee; Darko Pucar
Journal:  World J Nucl Med       Date:  2020-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.